Health Catalyst, Inc. (HCAT)

Health Catalyst's stock price experienced a significant decline over the past year. Key events impacting the stock in the past six months include Q2 2025 Earnings, where Health Catalyst reported an EPS miss but revenue was in line with expectations, and a restructuring impacting 9% of the workforce was noted. Health Catalyst was identified as the weakest Q2 performer among data analytics stocks. Health Catalyst's shares declined in Q2 2025, despite mixed earnings results. The company is scheduled to announce its third-quarter 2025 operating results on Monday, November 10, 2025. The company participated in several investor conferences.

Health Catalyst experiences some demand seasonality for its products and services. Historically, the first quarter (Q1) is typically a softer quarter for the company compared to the rest of the year. Additionally, October has historically favored a short bias for HCAT stock. Despite Q1 being a softer quarter, in Q1 2025, HCAT added 10 net new platform clients, putting it on track to meet its FY25 goal of 40 new client additions.

Health Catalyst, Inc. is a provider of data and analytics technology and services for healthcare organizations. The company operates within the Healthcare sector, specifically in the Health Information Services industry, with a focus on data analytics. Its core mission is to transform healthcare through data-driven insights. Its major products and services include the Data Operating System (DOS) / Ignite Platform, Analytics Applications, and Professional Services.

Health Catalyst, Inc. is headquartered in South Jordan, Utah, United States. The company has a global presence, with employees across six continents and subsidiaries in various countries, including India, Australia, the United Arab Emirates, and the United Kingdom.

Health Catalyst maintains a strong position within the healthcare analytics industry. Events and factors contributing to its brand reputation in the past year include strategic technology partnerships with Microsoft and Databricks, the introduction of Health Catalyst Ignite Spark, and the 2025 Catalyst Awards. The company demonstrates strong efficiency in acquiring new customers.

Health Catalyst, Inc. has a diverse ownership structure, with a significant portion held by institutional investors. Approximately 73% of the company's shares are held by institutions. Major institutional owners include First Light Asset Management, LLC, BlackRock, Inc., and Vanguard Group Inc. Individual investors hold approximately 14.34% of the shares, while company insiders hold about 5.88%. CEO Daniel Burton owns 1.5% of the company's shares.